Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2007 August;142(4) > Giornale Italiano di Dermatologia e Venereologia 2007 August;142(4):409-14

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

REVIEWS  PEMPHIGUS


Giornale Italiano di Dermatologia e Venereologia 2007 August;142(4):409-14

language: English

Pemphigus and drugs: our experience

Brenner S., Goldberg I.

Department of Dermatology Tel Aviv Sourasky Medical Center Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel


PDF  


Various drugs have been implicated in the induction and/or exacerbation of pemphigus. Nevertheless, many cases remain unrecognized. A detailed history – including analgesics, homeopathic drugs, immunizations, and ophthalmic preparations – can disclose the culprit. Elimination of the offending agents may ameliorate the disease and reduce the need for drug treatment. Diagnosis must also take into account the multifactorial nature of the disease, represented by the acronym PEMPHIGUS we proposed: PEsticides, Malignancy, Pharmaceuticals, Hormones, Infectious agents and Immunization, Gastronomy, Ultraviolet radiation, and Stress. A useful tool for identifying culprit drugs in pemphigus patients is the interferon-gamma (INF-γ) release test. Correlation between the results of the test and the clinical picture can lead to the correct diagnosis.

top of page

Publication History

Cite this article as

Corresponding author e-mail